NeuroHealing to Present at World Orphan Drug Congress USA 2015

Newton, Massachusetts¬†– April 2015.¬† NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds announces that Neal M. Farber, Ph.D., Chief Executive Officer, will present an overview of NH001 at the World Orphan Drug Congress USA taking place at the Washington Hilton, Washington D.C., April…